Related Experiment Videos
Graft-versus-host disease and animal models for scleroderma
1University of Colorado School of Medicine, Denver.
Current Opinion in Rheumatology
|December 1, 1990
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mast cells, T cells and abnormal fibrosis.
Immunology today·2014
Natural suppressor (NS) cells members of the LGL regulatory family.
Immunology today·2014
Increased ICAM-1 expression in the early stages of murine chronic graft-versus-host disease.
Clinical immunology and immunopathology·1994
Antinuclear antibodies and breast implants.
The Western journal of medicine·1994
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1994
New approaches to the management of cutaneous lupus.
Current opinion in rheumatology·2026
"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".
Current opinion in rheumatology·2026
Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?
Current opinion in rheumatology·2026
Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.
Current opinion in rheumatology·2026
Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.
Current opinion in rheumatology·2026
Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.
Current opinion in rheumatology·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026